Actemra 162 mg/0.9 mL prefilled syringe Images
Generic Name: tocilizumab
This medication has been identified as Actemra 162 mg/0.9 mL prefilled syringe. It is supplied by Genentech, Inc.
Actemra is used in the treatment of Giant Cell Arteritis; Cytokine Release Syndrome; Juvenile Idiopathic Arthritis; COVID-19; Polyarticular Juvenile Idiopathic Arthritis and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Actemra 162 mg/0.9 mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Actemra
- Generic Name
- tocilizumab
- Strength
- 162 mg/0.9 mL prefilled syringe
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0138
More about Actemra (tocilizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (45)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
